Edited by: Hans-Uwe Simon
A granular variant of CD63 is a regulator of repeated human mast cell degranulation
Version of Record online: 22 MAR 2010
© 2010 John Wiley & Sons A/S
Volume 65, Issue 10, pages 1242–1255, October 2010
How to Cite
Schäfer, T., Starkl, P., Allard, C., Wolf, R. M. and Schweighoffer, T. (2010), A granular variant of CD63 is a regulator of repeated human mast cell degranulation. Allergy, 65: 1242–1255. doi: 10.1111/j.1398-9995.2010.02350.x
- Issue online: 7 SEP 2010
- Version of Record online: 22 MAR 2010
- Accepted for publication 1 February 2010
Figure S1. A degranulation-specific anti human mast cell mAb does not cross-react with platelets, MalMe3, or U937 cells.
Figure S2. Protein N-glycosylation affects CD63 protein binding by DSαHMC-mAbs.
Figure S3. Cysteine cluster alignment of human tetraspanin proteins.
Figure S4. Effects of anti CD63 mAbs on the release of β-hexosaminidase and selected cytokines from activated human mast cells.
Table S1. Inventory of antibodies used in this Report.
Table S2. List of oligonucleotides (primers) used in this Report.
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
|ALL_2350_sm_FigS1.tif||126K||Supporting info item|
|ALL_2350_sm_FigS2.tif||117K||Supporting info item|
|ALL_2350_sm_FigS3.tif||434K||Supporting info item|
|ALL_2350_sm_FigS4.tif||116K||Supporting info item|
|ALL_2350_sm_TableS1-2.doc||69K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.